心血管疾病可预测早期青光眼的结构与功能进展
结果显示,以黄斑区神经节细胞-内丛状层(mGCIPL)变薄为主的患者高血压、降压药及他汀类药物使用率更高;高血压与OCT和视野进展风险增加相关,收缩压升高亦与结构进展风险相关,且其关联强度与眼压相当。
要点
- 以mGCIPL变薄为主的患者高血压患病率及降压药、他汀使用率显著高于稳定参照组。
- 高血压与OCT结构进展(OR 1.79)和视野功能进展(OR 1.92)风险增加相关。
- 基线收缩压每升高1个标准差(约21 mmHg),OCT和视野进展风险均增加。
核心结论
- 心血管疾病是青光眼进展的重要危险因素。
研究设计与样本
- 使用谱域OCT评估基线及纵向结构变薄,使用Humphrey视野(HVF)评估视野进展。
- 平均随访5.34±1.29年。
主要发现
- 校正年龄和心血管特征后,以mGCIPL变薄为主的患者高血压患病率更高(OR 2.70;95%CI 1.66-4.41;P<0.001)。
- 以mGCIPL变薄为主的患者降压药使用(OR 2.03;95%CI 1.20-3.46;P=0.008)和他汀使用(OR 1.98;95%CI 1.07-3.66;P=0.029)均高于参照组。
- 以pRNFL变薄为主的患者心血管疾病患病率及用药情况与参照组相当。
- 高血压与OCT进展风险增加相关(OR 1.79;95%CI 1.17-2.75;P=0.006),也与HVF进展风险增加相关(OR 1.92;95%CI 1.18-3.15;P=0.013)。
- 基线收缩压每升高1个标准差(约21 mmHg),OCT进展风险增加(OR 1.27;95%CI 1.01-1.63;P=0.041),HVF进展风险增加(OR 1.32;95%CI 1.01-1.73;P=0.043)。
关键数值与推荐
- 收缩压与结构进展的关联强度与眼压和结构进展的关联相当(OR 1.30;95%CI 1.01-1.67;P=0.039)。
临床怎么用
- 对早期青光眼患者应关注高血压等心血管疾病及用药情况,并将其纳入进展风险评估。
- 以mGCIPL变薄为主的患者可能更需要筛查和管理心血管危险因素。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To investigate the association between cardiovascular disease and baseline structural defects and disease progression in glaucoma. DESIGN: Prospective, longitudinal study of preperimetric and perimetric glaucoma. PARTICIPANTS: Two thousand six hundred twenty-eight eyes from 1314 participants recruited to the Progression Risk of Glaucoma: Relevant SNPs with Significant Association (PROGRESSA) study were evaluated for baseline and longitudinal structural thinning using spectral-domain OCT and for visual field progression on Humphrey visual field (HVF) assessment. METHODS: Patients were classified as either predominantly macula ganglion cell-inner plexiform layer (mGCIPL), predominantly peripapillary retinal nerve fiber layer (pRNFL), or both mGCIPL and pRNFL structural change at enrollment, and then evaluated for longitudinal OCT or HVF progression. Cardiovascular disease and medication characteristics of the participants were compared with a reference group of stable patients. MAIN OUTCOME MEASURES: OCT and HVF baseline status and longitudinal progression. RESULTS: After accounting for age and cardiovascular characteristics, patients with predominantly mGCIPL thinning at baseline showed a higher prevalence of hypertension (odds ratio [OR], 2.70; 95% confidence interval [CI], 1.66-4.41; P < 0.001), antihypertensive use (OR, 2.03; 95% CI, 1.20-3.46; P = 0.008), and statin use (OR, 1.98; 95% CI, 1.07-3.66; P = 0.029) than reference patients. Patients with predominantly pRNFL thinning exhibited a comparable prevalence of cardiovascular disease or medication with reference patients. Review of longitudinal OCT and HVF data (mean follow-up, 5.34 ± 1.29 years) showed that hypertension was associated with an increased risk of both OCT (OR, 1.79; 95% CI, 1.17-2.75; P = 0.006) and HVF progression (OR, 1.92; 95% CI, 1.18-3.15; P = 0.013). A 1-standard deviation (approximately 21 mmHg) increase in systolic blood pressure at baseline was associated with a greater risk of OCT progression (OR, 1.27; 95% CI, 1.01-1.63; P = 0.041) and HVF progression (OR, 1.32; 95% CI, 1.01-1.73; P = 0.043). The association between systolic blood pressure and structural progression was comparable to that observed between intraocular pressure and structural progression (OR, 1.30; 95% CI, 1.01-1.67; P = 0.039). CONCLUSIONS: Cardiovascular disease is an important risk factor for glaucoma progression.
引用
- Marshall H, Mullany S, Qassim A, et al. Cardiovascular Disease Predicts Structural and Functional Progression in Early Glaucoma. Ophthalmology. 2020. PMID: 32730956. doi:10.1016/j.ophtha.2020.06.067
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。